Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,106Revenue $M924Net Margin (%)-20.5Altman Z-Score5.9
Enterprise Value $M13,317EPS $-1.2Operating Margin %-13.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-18.3Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsN
Price/Sales14.05-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-8.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M162ROIC % (ttm)-6.3Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 80.74-35%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 80.74-24%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 80.74-3%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 80.7423%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 80.7430%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 80.7443%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 80.7477%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 80.74124%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 80.74145%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 80.74146%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 80.74207%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 80.74217%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 80.74217%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 80.74286%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 80.74286%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 80.74286%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 80.74370%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 80.74410%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 80.74485%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ajer Jeffrey RobertEVP, Chief Commercial Officer 2016-05-03Sell415$86.03-6.15view
BIENAIME JEAN JACQUESCEO 2016-05-02Sell36,500$85.01-5.02view
Davis George EricEVP, General Counsel 2016-03-14Sell1,996$86.21-6.34view
Ajer Jeffrey RobertSVP, Chief Commercial Officer 2016-03-04Sell1,255$88.42-8.69view
SPIEGELMAN DANIEL KEVP, CFO 2016-03-02Sell4,623$86.12-6.25view
BIENAIME JEAN JACQUESCEO 2016-03-01Sell10,000$84.28-4.2view
GREY MICHAEL GDirector 2016-02-22Sell7,500$800.92view
Davis George EricSVP, General Counsel 2015-12-16Sell1,362$100-19.26view
BIENAIME JEAN JACQUESCEO 2015-11-30Sell1,000$94.74-14.78view
LAWLIS V BRYANDirector 2015-11-16Sell8,550$106.9-24.47view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 13 2010 

More From Other Websites
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US : May... May 05 2016
BioMarin to Attend Upcoming Investor Conferences May 04 2016
BioMarin to Attend Upcoming Investor Conferences May 04 2016
BioMarin Pharmaceutical, Inc. :BMRN-US: Earnings Analysis: Q1, 2016 By the Numbers May 03 2016
BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment... May 03 2016
8:26 am Biomarin Pharm announces the EMA granted accelerated assessment for Cerliponase Alfa... May 03 2016
BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment... May 03 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 10-Q, Quarterly Report May 02 2016
Analysts Make Major Changes to Top Biotech Ratings May 01 2016
BioMarin (BMRN) Reports Narrower-than-Expected Q1 Loss Apr 29 2016
Edited Transcript of BMRN earnings conference call or presentation 28-Apr-16 8:30pm GMT Apr 29 2016
BioMarin reports 1Q loss Apr 28 2016
BioMarin reports 1Q loss Apr 28 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2016
BioMarin Announces First Quarter 2016 Financial Results Apr 28 2016
BioMarin Announces First Quarter 2016 Financial Results Apr 28 2016
Q1 2016 Biomarin Pharmaceutical Inc Earnings Release - After Market Close Apr 28 2016
Sanofi Presses Medivation to Hold Talks After $9.3B Offer Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)